NMN Dosage Guide UK 2026 — How Much Should You Take by Age?

NMN dosage guide UK 2026 how much NMN to take by age under 40 40-50 over 50 clinical trial research Charge Products

 

 ⚠️ Educational content only. NMN is a food supplement — not a medicine. No authorised EU/UK health claims exist for NMN. All dosage information is based on published research and is for educational context only — not personalised medical advice. Always consult your GP before starting any supplement regimen, especially if you are on prescription medication or have a medical condition.

CHARGE PRODUCTS · NMN DOSAGE GUIDE · JULY 2026

NMN Dosage Guide UK 2026 — How Much Should You Take by Age?

The most important question about NMN — and the one the supplement industry most often gets wrong. Here's what the published clinical trials actually say about NMN dosing by age group, why most people are underdosing, and why a NAD+ test is the only way to know if it's working.

📚 2026 Research 🩺 GP First Always 🔬 PubMed Referenced ⚠️ No Overclaiming

How much NMN should you take? It is the first question everyone asks — and the supplement industry does not make it easy to find a straight answer. Some brands say 250mg. Others push 1,000mg. The honest answer is that it depends significantly on your age, and the gap between what most people are taking and what the research suggests they should be taking is larger than most realise.

This guide covers what published human clinical trials actually say about NMN dosing by age group — from the evidence behind the 250mg starter dose to why adults over 50 may need considerably more. It also covers the most important thing most people skip entirely: testing your NAD+ levels before you start.

For a full overview of the NMN research landscape including human trial evidence, sublingual vs oral, NMN vs NR and purity testing, see our companion guide: Top 10 NMN Questions Answered — What the Science Shows 2026 →

Why NMN Dosage Matters More Than Most People Realise

NMN raises NAD+ levels. NAD+ declines with age. The relationship between age and NAD+ decline is well established — and it is the fundamental reason why dosage cannot be treated as a one-size-fits-all number.

20s
Peak NAD+
Baseline — decline begins gradually from late 20s
40s–50s
~50% Decline
NAD+ approximately half of peak levels
60s+
Steepest Decline
CD38 enzyme activity increases — breaks down NAD+ faster

NAD+ levels decline by roughly 50% between your 20s and 50s. This means that a dose sufficient to raise NAD+ levels in a 30-year-old may be completely insufficient to move the needle in someone aged 55 or 60 — because the starting point is dramatically lower and the CD38 enzyme, which actively breaks down NAD+, increases with age and inflammation, depleting reserves faster.

NMN Dosage by Age — What the Clinical Trials Show

Under 40
250mg daily — reasonable starting point

For adults under 40, NAD+ decline is less pronounced and a 250mg daily dose is a reasonable entry point. Under 40 years: consider 250mg daily for maintenance — NAD+ decline is less pronounced at this age and moderate doses provide solid benefits.

The landmark Yoshino et al. (2021) study in Cell Metabolism used 250mg daily and showed improved skeletal muscle insulin sensitivity in postmenopausal women — demonstrating that 250mg can produce measurable metabolic effects in the right population. However, for younger adults without significant NAD+ depletion, 250mg is appropriate.

Ages 40–50
500mg daily — well supported by trial data

For anti-ageing purposes, 500mg per day is a well-supported starting dose for adults in their 40s and 50s. The GeroScience multicenter trial (2022) tested 300mg, 600mg and 900mg daily in 80 middle-aged adults (40–65 years) over 60 days and found all doses significantly increased blood NAD+ levels — with 600mg producing optimal NAD+ elevation.

The RENEW Study (2025) using 500mg NMN for 60 days in adults with a mean age of 52 found a 44% increase in intracellular NAD+ levels — importantly measuring intracellular rather than blood NAD+, which is more relevant to cellular function.

Over 50
500–900mg daily — research-backed range

Adults over 60 may benefit from 500–900mg daily, based on clinical trials showing enhanced physical function at higher doses. This is where underdosing is most common — and most consequential. Adults over 50 taking 250mg are very likely not providing sufficient NMN to meaningfully restore NAD+ levels given the steeper decline at this age.

A January 2026 randomised controlled trial in 65 healthy adults found that 1,000mg per day NMN doubled circulating NAD+ levels over 14 days. For adults in their 50s and 60s where baseline NAD+ is significantly depleted, higher doses are needed to produce the same relative increase as lower doses achieve in younger adults.

⚠️ If you are over 50 and taking a dual NMN capsule (e.g. NMN + Trans-Resveratrol): check the actual NMN content per capsule. A 500mg dual capsule typically contains 250mg NMN + 250mg Resveratrol — meaning your actual NMN intake is 250mg, not 500mg. This is a very common source of underdosing in this age group.

Over 60
750–1,000mg daily — consider with GP guidance

For adults over 60, the NAD+ deficit is at its most pronounced and higher doses are most warranted by the biology. Adults over 50: starting at 250–500mg/day and evaluating over 8+ weeks is a reasonable approach — consult with your physician, particularly if you take prescription medications.

At this age group particularly, a NAD+ test before starting is strongly recommended — both to establish a baseline and to guide dose optimisation over time.

NMN Dosage Quick Reference — Based on Published Trials

Age Group Suggested Daily Dose Research Basis Our Products
Under 40 250mg daily Yoshino et al. (2021) · Irie et al. (2020) NMN 500mg →
40–50 500mg daily GeroScience RCT (2022) · RENEW Study (2025) NMN 500mg →
50–60 500–900mg daily GeroScience RCT · Huang et al. (2022) NMN 700mg →
Over 60 750–1,000mg daily RCT (Jan 2026) · GeroScience higher dose arms NMN 700mg ×2 →

All dosage guidance is educational — based on published research only. Not personalised medical advice. Consult your GP before starting. Food supplement — not a medicine.

⚠️ IMPORTANT — DUAL CAPSULE PRODUCTS

Are You Getting the NMN Dose You Think You Are?

This is one of the most common sources of NMN underdosing — and it catches a lot of people out. Dual NMN capsules — such as NMN + Trans-Resveratrol or NMN + CoQ10 — split the capsule contents between two active ingredients. A 500mg dual capsule typically contains:

250mg
NMN (Nicotinamide Mononucleotide)
250mg
Trans-Resveratrol (or other co-ingredient)

If you are over 50 and taking one dual capsule daily, your actual NMN intake is 250mg — not 500mg. For this age group, research suggests you need at least double that dose to meaningfully raise NAD+ levels. Always check the label for the NMN content specifically, not the total capsule weight.

🔬 The Most Important Thing You Can Do — Test Your NAD+ Levels

NMN does not produce effects you can feel day to day. It works at a cellular level — supporting energy metabolism, DNA repair and mitochondrial function. This means that unlike caffeine or a painkiller, subjective feeling is not a reliable measure of whether NMN is working.

Taking NMN supplements without measuring your baseline NAD+ levels is like driving in the dark without headlights. A NAD+ blood test — taken before you start and again after 8–12 weeks of consistent supplementation at your target dose — gives you objective evidence of whether your dose is working and whether it needs adjusting.

📋
Step 1
Take a NAD+ blood test before starting NMN — establish your baseline
💊
Step 2
Take NMN consistently at the age-appropriate dose for 8–12 weeks
🔬
Step 3
Retest NAD+ — compare against baseline. Adjust dose if needed.

Members of the NMN community on Reddit who have purchased our NMN and taken NAD+ blood tests before and after consistently report significant NAD+ increases with our products at appropriate doses. The test data — not subjective feeling — is the only reliable measure of whether supplementation is working at your dose.

NMN Safety — What the Research Shows

Scientists have studied doses from 150mg to 1,200mg daily with no major side effects reported. The most commonly reported side effects are mild and temporary — occasional nausea or light stomach discomfort, particularly when starting at higher doses.

Dose Studied Duration Safety Finding
250–500mg/day 10–12 weeks Well tolerated · no adverse effects
600–900mg/day 8–12 weeks Well tolerated · mild GI at onset in some
1,200mg/day 6 weeks Well tolerated · no serious adverse effects
2,000mg/day 2 weeks Well tolerated short-term · long-term data absent

⚠️ All human safety trials have been short-term (2–12 weeks). No long-term human safety data beyond this window exists. Always consult your GP before starting NMN, particularly if you are on prescription medication, have kidney disease, are pregnant or breastfeeding, or have a history of cancer. Food supplement — not a medicine.

RELATED GUIDE

Top 10 NMN Questions Answered — What the Science Shows 2026

What is NMN, human trial evidence, sublingual vs capsule, NMN vs NR, purity testing, UK legal status, safety data — all 10 most asked NMN questions answered with published research references.

Read the Full Guide →
⭐⭐⭐⭐⭐

"I've been buying from Charge for about 7 or 8 years by now, and I can assure you everything I've bought is high quality with prompt delivery."

— J.M. · Verified
⭐⭐⭐⭐⭐

"Been ordering from you for years and recommending you — your service, delivery, packaging and product are of high standards."

— S.K. · Verified
⭐⭐⭐⭐⭐

"Ultra fast delivery and good quality product."

— T.B. · Verified
Read all reviews on Trustpilot →

📚 Research References

Educational context only. Not health claims. All sources openly linked.

Yoshino et al. (2021) — NMN and insulin sensitivity in postmenopausal women · Cell Metabolism

PubMed 34015196 →

Irie et al. (2020) — First human NMN pharmacokinetics RCT · NPJ Aging

PubMed 33378646 →

Liao et al. (2021) — NMN and aerobic capacity in amateur runners · JISSN

PubMed 34514983 →

GeroScience Multicenter RCT (2022) — 300mg, 600mg, 900mg NMN in 80 adults aged 40–65 · GeroScience

PubMed 35708746 →

January 2026 RCT — NMN 1,000mg/day doubled circulating NAD+ in 65 healthy adults · Published January 2026

Renue By Science NMN Trial Database →

RENEW Study (2025) — 500mg NMN, 44% intracellular NAD+ increase in 60 days · mean age 52

RENEW Study Reference →

Verdin (2015) — NAD+ in ageing, metabolism and disease · Science

PubMed 24270807 →

Charge Products — Top 10 NMN Questions Answered 2026 (full human trial review)

chargeproducts.co.uk/blogs/news/top-10-nmn-questions-answered-uk-2026 →
Disclaimer: This article is for educational purposes only and does not constitute medical advice. NMN is a food supplement — not a licensed medicine. No authorised EU/UK health claims exist for NMN under retained Regulation 1924/2006. All dosage information is based on published research and is for educational context only — not personalised medical advice. Always consult your GP before starting NMN, particularly if you are on prescription medication, have kidney disease, are pregnant or breastfeeding, or have a history of cancer. All products mentioned are food supplements — not medicines. Not intended to diagnose, treat, cure or prevent any disease. Supplied by Big Idea Services Ltd, Co. No. 11645389, Unit 1, 8 Towerfield Road, Southend-on-Sea, Essex SS3 9QE. chargeproducts.co.uk

RELATED ARTICLES